Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

OncoAlert Colloquium Day 5: Genitourinary tumours and social media

Dr McBride, Dr Apolo, Dr Choueiri, Dr Morgan, Dr Agarwal
OncoAlert Colloquium Day 5: Genitourinary tumours and social media ( Dr McBride, Dr Apolo, Dr Choueiri, Dr Morgan, Dr Agarwal )
23 Dec 2020

OncoAlert Colloquium Day 4: Gynae-oncology, lymphoma, sarcoma and melanoma

Dr Dizon, Dr Trent, Dr Cordoba, Dr Rolfo, Dr Haanen
OncoAlert Colloquium Day 4: Gynae-oncology, lymphoma, sarcoma and melanoma ( Dr Dizon, Dr Trent, Dr Cordoba, Dr Rolfo, Dr Haanen )
23 Dec 2020

OncoAlert Colloquium Day 3: Breast cancer

Dr Lambertini, Dr Hamilton, Dr Rugo, Dr Tolaney, Dr Meattini, Ms Maues, Ms Karmo
OncoAlert Colloquium Day 3: Breast cancer ( Dr Lambertini, Dr Hamilton, Dr Rugo, Dr Tolaney, Dr Meattini, Ms Maues, Ms Karmo )
23 Dec 2020

OncoAlert Colloquium Day 2: Lung cancer and SIOG

Dr Willers, Dr Sequist, Dr Liu, Dr Peters, Dr Kanesvaran, Ms Feldman, Dr Battisti
OncoAlert Colloquium Day 2: Lung cancer and SIOG ( Dr Willers, Dr Sequist, Dr Liu, Dr Peters, Dr Kanesvaran, Ms Feldman, Dr Battisti )
23 Dec 2020

Highlights from the 2020 European Cancer Organisation (ECO) summit

Prof Matti Aapro - President, European Cancer Organisation (ECO), Switzerland
Highlights from the 2020 European Cancer Organisation (ECO) summit ( Prof Matti Aapro - President, European Cancer Organisation (ECO), Switzerland )
22 Dec 2020

Long-term follow-up of low-intensity chemotherapy with combination therapy for r/r Ph- acute lymphoblastic leukaemia patients

Prof Hagop Kantarjian - MD Anderson Cancer Center, Houston, USA
Long-term follow-up of low-intensity chemotherapy with combination therapy for r/r Ph- acute lymphoblastic leukaemia patients ( Prof Hagop Kantarjian - MD Anderson Cancer Center, Houston, USA )
22 Dec 2020

Results of venetoclax and azacitidine combination in chemotherapy ineligible untreated patients with AML

Prof Hagop Kantarjian - MD Anderson Cancer Center, Houston, USA
Results of venetoclax and azacitidine combination in chemotherapy ineligible untreated patients with AML ( Prof Hagop Kantarjian - MD Anderson Cancer Center, Houston, USA )
22 Dec 2020

A treatment comparison of carfilzomib, dexamethasone and daratumumab to daratumumab and bortezomib

Prof Evangelos Terpos - University of Athens, Athens, Greece
A treatment comparison of carfilzomib, dexamethasone and daratumumab to daratumumab and bortezomib ( Prof Evangelos Terpos - University of Athens, Athens, Greece )
22 Dec 2020

Real-world evidence of the use of carfilzomib to refractory to lenalidomide patients

Prof Evangelos Terpos - University of Athens, Athens, Greece
Real-world evidence of the use of carfilzomib to refractory to lenalidomide patients ( Prof Evangelos Terpos - University of Athens, Athens, Greece )
22 Dec 2020

Real-world evidence of the use of carfilzomib among multiple myeloma patients across 10 European countries and Israel

Prof Evangelos Terpos - University of Athens, Athens, Greece
Real-world evidence of the use of carfilzomib among multiple myeloma patients across 10 European countries and Israel ( Prof Evangelos Terpos - University of Athens, Athens, Greece )
22 Dec 2020

2020 updates in treating NTRK fusion cancer

Dr Alexander Drilon and Prof Marc Peeters
2020 updates in treating NTRK fusion cancer ( Dr Alexander Drilon and Prof Marc Peeters )
22 Dec 2020

PARP inhibitors for prostate cancer: What oncology PAs should know

Colleen Tetzlaf, PA-C, Fox Chase Cancer Center, Philadelphia, USA
PARP inhibitors for prostate cancer: What oncology PAs should know ( Colleen Tetzlaf, PA-C, Fox Chase Cancer Center, Philadelphia, USA )
18 Dec 2020